Sarah ArdenTeam Lead (Acting), New Technologies and Innovation Group: Manufacturing, Methods Development, Modeling/Simulations Science and Research Staff at Office of Pharmaceutical Quality (OPQ)/Center for Drug Evaluation and Research (CDER)
Dr. Arden leads the New Technologies and Innovation group in the Office of Pharmaceutical Quality CDER/FDA, focusing on advanced manufacturing, methods and modeling. She previously served as a CMC reviewer in the Office of Biotechnology Products. Dr. Arden received her Ph.D. in Chemical and Biomolecular Engineering from Johns Hopkins University and B.S. from the University of California, San Diego. She completed postdoctoral studies at ETH Zurich and Stanford University. Prior to joining FDA, Dr. Arden co-founded a digital health technology startup and worked as a technology advisor to industry and government clients.